Poland· PL-100368323

11C-cholina

A medicinal product containing choline (11c), registered in Poland by Voxel S.A..

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalised11C-cholinaATC—REGISTER NO.PL-100368323PACKS LISTED1CHECKEDAugust 30, 2026

The record

At a glance

URPL (Poland)
Active substance
Choline (11C)
Manufacturer
Voxel S.A.
Country
Poland (PL)
ATC code
—
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
August 30, 2026

Packs & prices · 1

  • gtin
    05909991286194

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Choline (11c) in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All choline (11c) products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/91488c55-e11b-4b38-8d32-aca14aae6f77
GET /v1/drugs/91488c55-e11b-4b38-8d32-aca14aae6f77?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań",
  "source": "urpl",
  "strength": "50 MBq/ml na dzień i godzinę odniesienia",
  "packaging": "05909991286194 ¦ Rpz ¦ 116869\n1 fiol. 15 ml",
  "substance": "Choline (11C) 50 MBq/ml na dzień i godzinę odniesienia",
  "common_name": "Choline (11C)",
  "pl_product_id": "100368323",
  "pozwolenie_nr": "23327",
  "auth_procedure": "NAR",
  "authorisation_validity": "2023-08-31"
}

See everything about choline (11c).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.